Diagnostic Approach to Venous Thromboembolism Based on D-dimer Levels

Introduction to D-dimer Significance

A D-dimer level of 10 mg/L is highly concerning and strongly suggests the presence of venous thromboembolism (VTE) or other serious pathology, warranting immediate diagnostic imaging 1, 2, 3
D-dimer levels >5 mg/L are associated with a remarkably high thrombotic risk, with a positive predictive value of at least 40-50% for thrombotic complications, particularly in patients with suspected VTE 1, 2, 3

Immediate diagnostic imaging is required for a D-dimer level of 10 mg/L, regardless of clinical probability assessment 1, 2, 3
For suspected pulmonary embolism (PE), proceed directly to CT pulmonary angiography (CTPA) or ventilation-perfusion (VQ) scan 4, 5
For suspected deep vein thrombosis (DVT), proceed directly to proximal lower extremity or whole-leg ultrasound 6, 7

In patients with low clinical probability of VTE, a D-dimer of 10 mg/L requires immediate imaging, and the American Society of Hematology recommends imaging for any positive D-dimer in low-risk patients 4, 8
A D-dimer level >5 mg/L is associated with a positive predictive value of approximately 50% for thrombotic complications in COVID-19 patients 1, 2, 3

D-dimer levels can be elevated in numerous non-thrombotic conditions, including COVID-19, pregnancy, recent surgery or trauma, advanced age, inflammatory states, malignancy, and sepsis 1, 2, 3, 9
Changes in D-dimer levels over time can help identify patients likely to develop thrombosis, with a 1.5-fold increase strongly associated with thrombosis diagnosis in COVID-19 patients 1, 2, 3

In selected patients with very high thrombotic risk (D-dimer >5 mg/L), therapeutic dose anticoagulation and screening for thrombosis should be considered, particularly in COVID-19 patients 1, 2, 3
For non-COVID patients with D-dimer of 10 mg/L, immediate diagnostic imaging should be performed before initiating therapeutic anticoagulation, unless there is a high clinical suspicion and imaging will be delayed 4, 5

D-dimer levels >5 mg/mL are associated with a remarkably high thrombotic risk, with a positive predictive value of approximately 50% for thrombotic complications, as suggested by the Anaesthesia journal 10, 11
In non-mechanically ventilated patients, D-dimer levels >5 mg/mL at admission are associated with venous thromboembolism in 46.7% of cases, according to the Anaesthesia journal 11
Among patients who underwent CT pulmonary angiography, D-dimer levels approaching 5 mg/mL had a positive predictive value for pulmonary embolism of approximately 70%, as reported in the Anaesthesia journal 11

The French Working Group on Perioperative Haemostasis (GIHP) recommends therapeutic anticoagulation for patients with D-dimer >5 mg/mL or a rapid increase in D-dimer levels, based on evidence from the Anaesthesia journal 10, 11
The 2022 CHEST guideline update suggests therapeutic dose heparin over standard dose thromboprophylaxis in patients with elevated D-dimer and low bleeding risk, as stated in the Chest journal 12
For patients with very high thrombotic risk defined by D-dimer >5 mg/mL, guidelines suggest initiating therapeutic dose anticoagulation and screening for thrombosis, according to the Anaesthesia journal 11, 13

For therapeutic anticoagulation with IV heparin, dosing should be adjusted based on weight and renal function, as recommended by the Anaesthesia journal 10, 13 and the Chest journal 12
For patients with creatinine clearance >30 mL/min, the Chest journal suggests using LMWH (e.g., enoxaparin 100 IU/kg/12h, not exceeding 10,000 IU/12h) or IV unfractionated heparin 12

The Critical Care journal advises against using D-dimer as the sole criterion for anticoagulation decisions; clinical assessment remains important, as stated in the Critical Care journal 14, 15
The Anaesthesia journal warns against relying solely on a single D-dimer measurement, as changes over time can be more informative 11